radiolabeled albumin technetium Tc-99m albumin colloid kit (Microlite) Report issue

Biological Imaging Approved FDA
AACT ChEMBL Drugs@FDA PubChem

Active Ingredient History

NOW
  • Now
Technetium 99mTc albumin aggregated (99mTc-MAA) is an injectable radiopharmaceutical used in nuclear medicine. It consists of a sterile aqueous suspension of Technetium-99m (99mTc) labeled to human albumin aggregate particles. It is commonly used for lung perfusion scanning. It is also less commonly used to visualise a peritoneovenous shunt and for isotope venography.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Imaging: 99-technetium
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Parenteral
  • Pro Drug: No

Alternative names

99mtc-albumin | 99mtc albumin macroaggregates | 99mtc human serum albumin colloid | an-maa | a-n stannous aggregated albumin | instant microspheres | lungaggregate reagent | macrotec | microlite | mp-4006 | pulmolite | tc-99m albumin | tc-99m human serum albumin (hsa) | tc 99m-lungaggregate | tc-99m mp-4006 | technescan maa | technetium | technetium-99m macroaggregated albumin | technetium tc 99m albumin | technetium tc 99m albumin aggregated | technetium tc-99m albumin aggregated | technetium tc 99m albumin aggregated kit | technetium tc-99m albumin aggregated kit | technetium tc 99m albumin colloid | technetium tc-99m albumin colloid | technetium tc-99m albumin colloid kit | technetium tc-99m albumin kit | technetium tc-99m albumin microspheres kit | technetium tc 99m hsa | technetium tc 99m maa

Organizations (17)

Research & Development (9)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (8)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (7)

Approved Indications (1)


 

Diagnostic Imaging (approved 1983)

Experimental Indications - Clinical Trial Phases 1-4 (6)


 

Breast Neoplasms (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Colorectal Neoplasms (Phase 2)

Coronary Artery Disease (Phase 3)

Neoplasm Metastasis (Phase 2)

Opioid-Related Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial Organizations: 9

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue